100 related articles for article (PubMed ID: 19878775)
1. Chapter 7: Cell protective functions of secretory Clusterin (sCLU).
Klock G; Baiersdörfer M; Koch-Brandt C
Adv Cancer Res; 2009; 104():115-38. PubMed ID: 19878775
[TBL] [Abstract][Full Text] [Related]
2. Chapter 4: Regulation of Clusterin activity by calcium.
Pajak B; Orzechowski A
Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
[TBL] [Abstract][Full Text] [Related]
3. Clusterin: a forgotten player in Alzheimer's disease.
Nuutinen T; Suuronen T; Kauppinen A; Salminen A
Brain Res Rev; 2009 Oct; 61(2):89-104. PubMed ID: 19651157
[TBL] [Abstract][Full Text] [Related]
4. CLU "in and out": looking for a link.
Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
[TBL] [Abstract][Full Text] [Related]
5. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands.
Gliemann J
Biol Chem; 1998; 379(8-9):951-64. PubMed ID: 9792428
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y cells.
Carreras I; Garrett-Young R; Ullman MD; Eisenhauer PB; Fine RE; Wells JM; Conn KJ
J Neurosci Res; 2005 Feb; 79(4):495-502. PubMed ID: 15635600
[TBL] [Abstract][Full Text] [Related]
7. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
Schwarz M; Spath L; Lux CA; Paprotka K; Torzewski M; Dersch K; Koch-Brandt C; Husmann M; Bhakdi S
Thromb Haemost; 2008 Jul; 100(1):110-8. PubMed ID: 18612545
[TBL] [Abstract][Full Text] [Related]
8. At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1.
Bustin M
Sci STKE; 2002 Sep; 2002(151):pe39. PubMed ID: 12297673
[TBL] [Abstract][Full Text] [Related]
9. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
Kadam R; Harish M; Dalvi K; Teni T
Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
[TBL] [Abstract][Full Text] [Related]
10. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
Lee JY; Kim HJ; Rho SB; Lee SH
Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: Apoptosis.
Kataoka S; Tsuruo T
Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
[TBL] [Abstract][Full Text] [Related]
12. The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitro.
Zhang Q; Zhou W; Kundu S; Jang TL; Yang X; Pins M; Smith N; Jovanovic B; Xin D; Liang L; Guo Y; Lee C
BJU Int; 2006 Aug; 98(2):452-60. PubMed ID: 16879694
[TBL] [Abstract][Full Text] [Related]
13. Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family.
Wallach D; Boldin M; Goncharov T; Goltsev Y; Mett I; Malinin N; Adar R; Kovalenko A; Varfolomeev E
Behring Inst Mitt; 1996 Oct; (97):144-55. PubMed ID: 8950472
[TBL] [Abstract][Full Text] [Related]
14. All in the family: evolutionary and functional relationships among death receptors.
Bridgham JT; Wilder JA; Hollocher H; Johnson AL
Cell Death Differ; 2003 Jan; 10(1):19-25. PubMed ID: 12655292
[TBL] [Abstract][Full Text] [Related]
15. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in liver disease.
Schattenberg JM; Galle PR; Schuchmann M
Liver Int; 2006 Oct; 26(8):904-11. PubMed ID: 16953829
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26033. PubMed ID: 22016805
[TBL] [Abstract][Full Text] [Related]
18. Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.
Wyatt A; Yerbury J; Poon S; Dabbs R; Wilson M
Adv Cancer Res; 2009; 104():89-114. PubMed ID: 19878774
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor and trail interactions in epithelial-derived cells.
Gibson SB
Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179
[TBL] [Abstract][Full Text] [Related]
20. Messengers of cell death: apoptotic signaling in health and disease.
Rossi D; Gaidano G
Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
